Omada Health, Inc. (OMDA)

Omada Health, Inc. is trading at $23.08, down 5.99% on the session. The 50 day average sits at $22.32 and the 200 day at $16.94, which puts the stock in a uptrend. RSI is at 60.7, which reads as strong, and MACD is bearish crossover. Volume is average.

The nearest support is around $23.42 with resistance near $24.97, so that band frames the current range. Average daily movement is roughly $1.08, or about 4.7% of the share price, which is what any stop placement has to allow for. The overall health score of 71 out of 100 combines a trend score of 100, momentum of 64 and a risk score of 36.

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.